Randomised phase II trial of gemcitabine and nab-paclitaxel with necuparanib or placebo in untreated metastatic pancreas ductal adenocarcinoma

Authors:

Abstract
No abstract available
Funding Information
  • Memorial Sloan Kettering Cancer Center (CA0008748)

This publication has 28 references indexed in Scilit: